Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Sufentanil for Induction of General Anesthesia in Neurosurgery
ChiCTR2000038469Phase 4Recruiting
- Sponsor
- Beijing Sanbo Brain Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Benign intracranial neoplasm and Spinal Cord Abnormalities (2 arms), sponsored by Beijing Sanbo Brain Hospital. Primary endpoint: Hemodynamics. Started Oct 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
Benign intracranial neoplasmSpinal Cord Abnormalities
Beyond the preview
Go deeper on ChiCTR2000038469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038469.